Subscribe
gavel-pills-istock-525883642-vnphotolab-
AVNphotolab / iStockphoto.com
11 June 2018Americas

Takeda v Zydus: FTC intervenes in sham lawsuit claims

The US Federal Trade Commission ( FTC) has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Actavis and Zydus settle with Supernus over seizure drug
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Actavis and Zydus settle with Supernus over seizure drug
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Actavis and Zydus settle with Supernus over seizure drug
13 March 2017   Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB